Deep Dive on Oncology | pharmaphorum

Deep Dive

Views & Analysis

ASCO 2020: Scientific advances & what’s impacting doctors an...

Despite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s Richard Staines that the 2020 American Society of Clini

Views & Analysis

Deep Dive: The Future of Oncology

This year’s ASCO showed us that while COVID-19 might be front and centre of everyone’s minds, the desire to see real change in cancer treatment hasn’t diminished. In this issue

Deep Dive

The promise and pitfalls of molecular testing in oncology

Great strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain that frustrate both physicians and patients.

Deep Dive

Smarter thinking about pharmaceutical marketing

Robb DeFilippis, from end-to-end global creative production and sourcing partner Tag, discusses how a more effective multichannel pharma marketing approach can positively affect patient out

Views & Analysis

Getting patients round the virtual table

If pharma wants to be truly patient-centric, it needs to be talking to patients.

Deep Dive

Revealing the true value of new cancer drugs to payers

Marc Botteman and Ben van Hout from Pharmerit International discuss how to navigate the value challenges of new cancer treatments like CAR-T with payers.

ASCO 2020: Scientific advances & what’s impacting doctors an...

Deep Dive: The Future of Oncology

The promise and pitfalls of molecular testing in oncology

Smarter thinking about pharmaceutical marketing

Getting patients round the virtual table

Revealing the true value of new cancer drugs to payers

CDMOs: Their crucial role and how to select one, with Sigma ...

How to meet your physicians where they are online

Deep Dive

Editor's Picks